
IBAC Valuation
IB Acquisition Corp
- Overview
- Forecast
- Valuation
- Earnings
IBAC Relative Valuation
IBAC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IBAC is overvalued; if below, it's undervalued.
Historical Valuation
IB Acquisition Corp (IBAC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of IB Acquisition Corp (IBAC) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:10.51
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
IB Acquisition Corp. (IBAC) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
IB Acquisition Corp. (IBAC) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
IB Acquisition Corp. (IBAC) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
IB Acquisition Corp. (IBAC) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
IB Acquisition Corp. (IBAC) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
IB Acquisition Corp (IBAC) has a current Price-to-Book (P/B) ratio of 276.03. Compared to its 3-year average P/B ratio of 142.71 , the current P/B ratio is approximately 93.42% higher. Relative to its 5-year average P/B ratio of 142.71, the current P/B ratio is about 93.42% higher. IB Acquisition Corp (IBAC) has a Forward Free Cash Flow (FCF) yield of approximately -0.79%. Compared to its 3-year average FCF yield of -0.59%, the current FCF yield is approximately 35.01% lower. Relative to its 5-year average FCF yield of -0.59% , the current FCF yield is about 35.01% lower.
276.03
P/B
Median3y
142.71
Median5y
142.71
-0.79
FCF Yield
Median3y
-0.59
Median5y
-0.59
Competitors Valuation Multiple
The average P/S ratio for IBAC's competitors is 0.00, providing a benchmark for relative valuation. IB Acquisition Corp Corp (IBAC) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IBAC increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IBAC in the past 1 year is driven by Unknown.
People Also Watch

ARTV
Artiva Biotherapeutics Inc
2.880
USD
+3.97%

MPTI
M-Tron Industries Inc
44.910
USD
+3.96%

PEBK
Peoples Bancorp of North Carolina Inc
31.850
USD
+7.42%

TWIN
Twin Disc Inc
10.970
USD
-2.14%

DOUG
Douglas Elliman Inc
2.660
USD
+6.83%

CBNA
Chain Bridge Bancorp Inc
28.380
USD
+3.96%

STRS
Stratus Properties Inc
19.480
USD
+8.04%

CHSN
Chanson International Holding
2.260
USD
+2.73%

ZNTL
Zentalis Pharmaceuticals Inc
1.990
USD
+6.42%

CHRS
Coherus Oncology Inc
1.230
USD
+8.85%
FAQ

Is IB Acquisition Corp (IBAC) currently overvalued or undervalued?
IB Acquisition Corp (IBAC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of IB Acquisition Corp (IBAC) is between to according to relative valuation methord.

What is IB Acquisition Corp (IBAC) fair value?

How does IBAC's valuation metrics compare to the industry average?

What is the current P/B ratio for IB Acquisition Corp (IBAC) as of Aug 23 2025?

What is the current FCF Yield for IB Acquisition Corp (IBAC) as of Aug 23 2025?

What is the current Forward P/E ratio for IB Acquisition Corp (IBAC) as of Aug 23 2025?
